In addition, it has been reported that, reduced thrombospondin-1 expression is associated with disease recurrence, decreases survival and disease progression [ 14, 17].
Recently, it has been reported that reduced graphene oxide (rGO) works synergistically with catalyst particles to enhance their stability and performance [33, 34, 35, 36].
Generally, for these materials, the adsorption is a practical and common application and it has been reported that reduced graphene oxid with its derivative could effectively absorb manifold organic dyes, such as methylene blue (MB), Rhodamine B (RhB), through π-π stacking, hydrogen bonding, the electrostatic force, etc. [10, 11].
It has been reported that reduced cardiac VEGF signaling interferes with myocardial angiogenesis, resulting in local ischemia, which triggers cardiomyocyte damage and heart failure [32].
Besides gastric cancer, it has been reported that reduced expression of RUNX3 was observed in various cancers including bladder, liver, colorectal and lung cancers [5] [8].
Moreover, it has been reported that reduced expression of RUNX3 was observed in various cancers including bladder, liver, colon and lung cancers [5] [8].
Reduced salivary flow rate is a consistent finding in CKD patients and it has been reported that reduce flow is due to effects of drugs, emotional stress and neuropathy in CKD patients [ 43].
In song-birds, it has been reported that reducing the expression of FoxP2 in an area of the brain necessary for vocal learning can interfere with the song learning process [ 33].
It has also been reported that DMTU reduced brain infarction and edema after permanent MCAO in rats [33].
It has been reported that EDA reduced the oxidative damage caused by A β25 35 in PC12 cells, decreased apoptosis, and increased intracellular glutathione and superoxide dismutase concentrations [ 13].
It has been reported that, when reducing equivalents accumulate in the mitochondria, the activity of the malate-OAA shuttle will be reduced by a feedback mechanism [ 47].
